Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
31.94 USD | +1.49% | +12.98% | +39.29% |
Financials (USD)
Sales 2024 * | 270M | Sales 2025 * | 120M | Capitalization | 1.85B |
---|---|---|---|---|---|
Net income 2024 * | 77M | Net income 2025 * | 2M | EV / Sales 2024 * | 5.2 x |
Net cash position 2024 * | 442M | Net cash position 2025 * | 677M | EV / Sales 2025 * | 9.76 x |
P/E ratio 2024 * |
27.7
x | P/E ratio 2025 * |
-32.5
x | Employees | 124 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 98% |
Latest transcript on Protagonist Therapeutics, Inc.
1 day | +1.49% | ||
1 week | +17.82% | ||
Current month | +27.20% | ||
1 month | +20.17% | ||
3 months | +13.14% | ||
6 months | +96.07% | ||
Current year | +39.29% |
Managers | Title | Age | Since |
---|---|---|---|
Dinesh Patel
CEO | Chief Executive Officer | 67 | 08-11-30 |
Asif Ali
DFI | Director of Finance/CFO | 50 | 22-04-17 |
Chief Tech/Sci/R&D Officer | - | 17-06-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Lewis Williams
BRD | Director/Board Member | 74 | 17-06-07 |
Harold Selick
CHM | Chairman | 69 | 09-01-31 |
Daniel Swisher
BRD | Director/Board Member | 61 | 23-10-25 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.06% | 2 M€ | -.--% | ||
0.05% | 0 M€ | 0.00% | - | |
0.04% | 0 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-16 | 31.94 | +1.49% | 467,656 |
24-05-15 | 31.47 | +6.28% | 676,139 |
24-05-14 | 29.61 | +0.99% | 541,009 |
24-05-13 | 29.32 | +3.86% | 541,028 |
24-05-10 | 28.23 | -0.14% | 513,289 |
Delayed Quote Nasdaq, May 16, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+39.29% | 1.85B | |
+33.37% | 49.46B | |
+1.55% | 42.58B | |
+49.11% | 42.49B | |
-4.22% | 29.09B | |
+11.57% | 26.61B | |
-21.00% | 18.64B | |
+7.36% | 13.16B | |
+28.30% | 12.55B | |
+23.80% | 12.1B |
- Stock Market
- Equities
- PTGX Stock